A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis
<p>Abstract</p> <p>Background</p> <p>Extracellular matrix metalloproteinase inducer (EMMPRIN; CD147, basigin) is an inducer of the expression of several matrix metalloproteinases (MMPs). We reported previously that blocking EMMPRIN activity reduced neuroinflammation and...
Main Authors: | Agrawal Smriti M, Silva Claudia, Wang Janet, Tong Jade, Yong V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://www.jneuroinflammation.com/content/9/1/64 |
Similar Items
-
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants
by: Gholamreza Azizi, et al.
Published: (2014-06-01) -
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis
by: Kabir Magaji Hamid, et al.
Published: (2016-01-01) -
EMMPRIN expression is associated with metastatic progression in osteosarcoma
by: Han-Soo Kim, et al.
Published: (2021-09-01) -
The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
by: Hong-Meng Chuang, et al.
Published: (2019-11-01) -
Metaloproteinasas de la matriz extracelular (mmps) en Odontología
by: Vanesa Pereira Prado, et al.